Rotavirus Vaccine (Live Attenuated Oral) I.P. (Freeze-Dried)

Vaccine Overview

The Rotavirus Vaccine (Live Attenuated Oral) I.P. (Freeze-Dried) is used to protect against rotavirus infections, which cause severe diarrhea in infants and young children. This oral vaccine contains live, weakened rotavirus strains and is reconstituted before administration. It is typically given in two or three doses starting at 6-8 weeks of age, with subsequent doses at 4-6 weeks intervals. It helps prevent hospitalization due to rotavirus-related diarrhea and dehydration, contributing to overall childhood health.

Drug Class: Viral Vaccines

Indication: Rotavirus Vaccine, Live Attenuated (Oral) is indicated for active immunization of healthy infants from the age of 6 weeks for the prevention of gastroenteritis due to rotavirus infection when administered as a 3-dose series

PREVENTS

Rotavirus

Vaccine Details

Applied To

Infants, Children, Adolescents, Adults

Recommended Time

First dose at 6–8 weeks, second dose at 4–6 weeks after first dose, third dose (if applicable) at 14–16 weeks

Administration

Route: Rotavirus Vaccine, Live Attenuated (Oral) is for ORAL ADMINISTRATION ONLY AND MUST NOT BE ADMINISTERED PARENTERALLY

Site: Administered orally directly into the infant's mouth after reconstitution (no injection site)

Disease

Rotavirus

Manufacturer

Serum Intitute Of India

Age

Infants (6–16 weeks)

Disclaimer

This information is provided for educational purposes only and should not replace professional medical advice. Always consult with a healthcare professional before getting vaccinated or if you have any concerns about vaccines or side effects.

Last updated: May 2, 2025